Friederike Holze, PhD has been a member of the Psychopharmacology Research Group at the University Hospital Basel since 2017, after completing her Pharmacy studies at the University of Basel from 2011 to 2016. Her work, under the mentorship of Prof. Matthias E. Liechti, involves the detailed study of the pharmacology of psychoactive substances such as LSD, psilocybin, and MDMA.
Earning her PhD in 2021 for her work in this area, Dr. Holze has significantly contributed to the field through her research and publications. Her in-depth studies, have offered valuable insights to the clinical pharmacology of psychedelics. In the course of her research, Dr. Holze has also facilitated around 200 psychedelic experiences, which have further enhanced her comprehensive understanding of these substances.
Dr. Holze received several prizes for her research, including the prestigious NEATOR award from the ACNP for her study investigating the direct comparison between LSD and psilocybin in healthy individuals. Her commitment to understanding the effects of psychoactive compounds has significantly contributed to the field of psychedelics, offering valuable insights and aiding in the advancement of scientific knowledge.